In 2002, Voskuhl was part of the investigative team that found that treating non-pregnant women with 8 mg/day estriol helped to relieve symptoms, including lesion number and volume. Upon cessation of treatment, lesion number and volume returned to pre-treatment levels. After reinstituting treatment, lesion number and volume again decreased significantly.